Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/ade248f3-63b0-47f0-afd4-0592457ef7e1/

LOVE

Cannara Biotech Inc.
Chart
1.68 CAD
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericMICRO
Snapshot 2026-06-07 · 0.0w · Fresh
0.95
OS Score
92.0%
Value
82.0%
Quality
69.0%
Momentum
7/9
F-Score
0.869
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
8 of 23 passing
★
OS Composite
OS 0.950
↗
Trending Value
✗
◆
Quality × Value
QV 0.869
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
13.7%
◐
Veiled Value
✗
▣
Piotroski Bargains
F7
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
Rev +31%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 47%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 92th
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.43
V
Value Analysis
Cheapness relative to fundamentals
92.0%ile
P/E
16.3×
P/S
1.5×
P/B
1.4×
E/P
0.0997
FCF Yield
0.090
EBITDA/EV
0.137
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
13.00000000
/100 — 1=cheapest
VC2 (Trending Value)
23.00000000
/100
VC3 (Buyback)
20.00000000
/100
FCF yield of 9.0% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
82.0%ile
ROE
0.085
ROA
0.056
Net Margin
0.090
Op Margin
0.157
GPA
0.263
Current
3.06
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.311
Earn Growth
1.000
Stability
0.479
lower=better
Accruals
-0.096
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
69.0%ile
6M Return
-0.6%
12M Return
40.0%
12-1 Mom
46.7%
Risk-Adj
1.43
Vol 252d
32.6%
Vol 60d
61.9%
↑ Expanding
Max DD 12M
-15.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 47% is very strong — a clear uptrend. Near-term vol (62%) is expanding vs long-term (33%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.95
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 45 peers
Sector Value %ile
97.8%
Sector Quality %ile
87.0%
P/E z-score
-0.45
P/B z-score
-0.52
Sector Avg OS
46.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
XLY Auxly Cannabis Group Inc. 98.0% 96.0% 86.0% 85.0%
DR Medical Facilities Corporation 91.0% 90.0% 91.0% 29.0%
BHC Bausch Health Companies Inc. 90.0% 87.0% 96.0% 27.0%
TSND TerrAscend Corp. 86.0% 63.0% 62.0% 93.0%
MDP Medexus Pharmaceuticals Inc. 83.0% 62.0% 77.0% 67.0%
CRRX CareRx Corporation 81.0% 81.0% 68.0% 29.0%
TLRY Tilray Brands, Inc. 80.0% 75.0% 6.0% 99.0%
LABS MediPharm Labs Corp. 73.0% 59.0% 60.0% 61.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (92th) and quality (82th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Growth at Reasonable Price
Revenue growing 31% with P/E of 16×. Growth isn't fully priced in.
Volatility Expanding
60-day vol (62%) significantly exceeds 252-day (33%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
68.6% avg (7 factors)
Quality
C
58.4% avg (7 factors)
Momentum
B
67.8% avg (4 factors)
Risk
B
62.3% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.950—1—
Value %ile0.920—1—
Quality %ile0.820—1—
Momentum %ile0.690—0—
F-Score7.000—1—
Confidence0.926—1—
Volatility0.326—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
16.34
Earnings Yield (E/P)
0.0997
Price / Sales
1.47
Price / Book
1.38
Price / Cash Flow
6.00
FCF Yield
9.0%
EBITDA / EV
13.7%
Sales Yield (1/P·S)
0.6329
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
8.5%
Return on Assets
5.6%
Net Margin
9.0%
Operating Margin
15.7%
Gross Profit / Assets
Novy-Marx GPA
26.3%
Current Ratio
3.06
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.096
MomentumPrice trend strength over different horizons
6M Return
-0.6%
12M Return
40.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
46.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.43
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
31.1%
Earnings Growth (YoY)
100.0%
Earnings Stability (CV)
Lower = more stable
0.479
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
13
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
23
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
20
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity